[
  {
    "ts": null,
    "headline": "Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial",
    "summary": "Johnson & Johnson (NYSE:JNJ) ranks among the top stocks for an early retirement portfolio. On June 13, Johnson & Johnson (NYSE:JNJ) announced that patients with relapsed or refractory large B-cell lymphoma (LBCL) showed strong response rates to its investigational dual-targeting CAR T-cell treatment. According to results given at the 2025 European Hematology Association Congress, the […]",
    "url": "https://finnhub.io/api/news?id=36fea0d1735375f09e80422267b33dcc1991407fcdcaf9e83f2a92ac0be9199b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750878521,
      "headline": "Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial",
      "id": 135535007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) ranks among the top stocks for an early retirement portfolio. On June 13, Johnson & Johnson (NYSE:JNJ) announced that patients with relapsed or refractory large B-cell lymphoma (LBCL) showed strong response rates to its investigational dual-targeting CAR T-cell treatment. According to results given at the 2025 European Hematology Association Congress, the […]",
      "url": "https://finnhub.io/api/news?id=36fea0d1735375f09e80422267b33dcc1991407fcdcaf9e83f2a92ac0be9199b"
    }
  },
  {
    "ts": null,
    "headline": "6 Stocks to Buy to Give Your Portfolio the Perfect Mix of Growth, Value, and Defense",
    "summary": "This blend of stocks may be the key to long-term success.",
    "url": "https://finnhub.io/api/news?id=e8e4bd9547263b5ff0c399fc0b71af3b6ec2ca1cb2055572ca6975e97508a991",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750851002,
      "headline": "6 Stocks to Buy to Give Your Portfolio the Perfect Mix of Growth, Value, and Defense",
      "id": 135524420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "This blend of stocks may be the key to long-term success.",
      "url": "https://finnhub.io/api/news?id=e8e4bd9547263b5ff0c399fc0b71af3b6ec2ca1cb2055572ca6975e97508a991"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
    "summary": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
    "url": "https://finnhub.io/api/news?id=a3823b4eab8a3b599bb3f96eadd46ece5ce0a8a1b93cde82204d858cec42fb25",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750843166,
      "headline": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
      "id": 135525019,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a3823b4eab8a3b599bb3f96eadd46ece5ce0a8a1b93cde82204d858cec42fb25"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems. The systems are designed to treat the two […]",
    "url": "https://finnhub.io/api/news?id=4f9cdd5316a0c11e841decbfb59986ebc551facff860bb673f765167ab88a238",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750840177,
      "headline": "Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US",
      "id": 135522204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems. The systems are designed to treat the two […]",
      "url": "https://finnhub.io/api/news?id=4f9cdd5316a0c11e841decbfb59986ebc551facff860bb673f765167ab88a238"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys",
    "summary": "Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.",
    "url": "https://finnhub.io/api/news?id=28d3b832c1fca31770119594903f09760ded636b8898fcc7533e46ddeeaa3cac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750839000,
      "headline": "My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys",
      "id": 135524419,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.",
      "url": "https://finnhub.io/api/news?id=28d3b832c1fca31770119594903f09760ded636b8898fcc7533e46ddeeaa3cac"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best Fortune 500 stocks to buy according to billionaires. On June 19, Johnson & Johnson (J&J) MedTech introduced two new plating systems for distal radius (wrist) and proximal humerus (upper arm near the shoulder) fractures for its Variable Angle Optimised Locking Technology /VOLT platform in the US. […]",
    "url": "https://finnhub.io/api/news?id=6cd33dac0a0df38db1b9e3319d9b00527e0b5f8dadfb7db672a0ec75a8f6d29b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750837667,
      "headline": "Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems",
      "id": 135522205,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best Fortune 500 stocks to buy according to billionaires. On June 19, Johnson & Johnson (J&J) MedTech introduced two new plating systems for distal radius (wrist) and proximal humerus (upper arm near the shoulder) fractures for its Variable Angle Optimised Locking Technology /VOLT platform in the US. […]",
      "url": "https://finnhub.io/api/news?id=6cd33dac0a0df38db1b9e3319d9b00527e0b5f8dadfb7db672a0ec75a8f6d29b"
    }
  }
]